Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase NA 1Phase EARLY_PHASE1 1Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Lymphoma 40Lymphoma, Non-Hodgkin 37Lymphoma, B-Cell 36Precursor Cell Lymphoblastic Leukemia-Lymphoma 34Burkitt Lymphoma 27Lymphoma, Large B-Cell, Diffuse 21Lymphoma, Follicular 20Leukemia, Lymphocytic, Chronic, B-Cell 16Lymphoma, Mantle-Cell 15Leukemia 13Recurrence 12Multiple Myeloma 12Hodgkin Disease 12Leukemia, Myeloid, Acute 10Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 9Lymphoma, T-Cell 9Myelodysplastic Syndromes 8Lymphoma, T-Cell, Peripheral 8Mycosis Fungoides 6Lymphoma, T-Cell, Cutaneous 6Leukemia, B-Cell 6Sarcoma 5Neoplasms, Plasma Cell 5Neoplasms 5Melanoma 5Lymphoma, Extranodal NK-T-Cell 5Lymphoma, B-Cell, Marginal Zone 5Waldenstrom Macroglobulinemia 4Primary Myelofibrosis 4Lymphoma, Large-Cell, Anaplastic 4

Interventions

Insulin Lispro 1Insulin Glargine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Hyperglycemia × Lymphoid × Clear all
NCT02012465 2018-05-07

Validation of Insulin Protocol for Glucocorticoid-induced Hyperglycemia in Diabetic Oncology Patients

Washington University School of Medicine

Phase EARLY_PHASE1 Completed
15 enrolled
Lymphoid

Diabetes Mellitus, Type 2, Hyperglycemia, Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡